TNF and Sepsis: Unlike interleukin-1 receptor antagonist or monoclonal antibody to human tumor necrosis factor alpha biologics in treatment of sepsis, granisetron exerts its effect by suppressing the inflammatory signaling pathway, rather than acting on just one downstream mediator of inflammation, which allows it to play a more important role in the immunoregulation of sepsis.